Open Orphan CCO Maurice Treacy discusses the early adopters of ORPH’s Genomic Health DataBANK platform on the Vox Markets Podcast November 26, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan plc is a European-focused, rare and orphan drug consulting services platform. The Company intends to roll up a number of orphan drug services businesses. Open Orphan has two data driven digital platforms, a Genomic Health Data Platform, which is establishing a rare disease database and a Virtual Rep platform, enabling pharmaceutical companies to engage key opinion leaders and physicians. The Company is targeting rapid growth in one of the fastest growing sectors in…

Open Orphan (ORPH) – Early adopters signed for Genomic Health DataBANK November 25, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, is pleased to announce it has signed five pharmaceutical and biotechnology companies as early adopters of its Genomic Health DataBANK platform. The platform is expected to be completed and rolled out in Q1 2020. The five companies signed up to the Genomic Health DataBANK platform will ensure the database is ‘fit-for-purpose’ from a pharmaceutical and data analysis perspective ahead of the first patient data upload. This builds…

Open Orphan (ORPH) Contract signed with Carna Bioscience November 18, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, is pleased to announce the signing of a contract with Carna Bioscience (“Carna”) (www.carnabio.com) for a First In Human Clinical pharmacology trial. The contract is expected to deliver significant revenue for the Company over the next twelve months. Carna is a Japanese company specialising in kinase biology, developing innovative treatments against cancer and immune disorders. This contract sees Venn Life Sciences (“Venn”), part…

Open Orphan (ORPH) to attend Jefferies 2019 London Healthcare Conference November 15, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, is pleased to announce that the Company will be attending the Jefferies 2019 London Healthcare Conference on 20th-21st November 2019 in London, UK. The conference will be attended by a range of international healthcare executives and institutional investors who will gather to address near and long-term investment opportunities and to discuss the mechanisms driving global healthcare. Open Orphan’s Chief Executive Officer, Cathal Friel, will be in attendance and will…

Open Orphan’s (ORPH) Maurice Treacy Hosts Value the Markets Webinar October 24, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, announces that the Company’s Chief Commercial Officer, Maurice Treacy, will be hosting a webinar alongside Value the Markets on Wednesday 30th October 2019 at 19:00 (UK time). Maurice Treacy will take the opportunity to update existing and potential shareholders on Open Orphan and will provide an insight on the Company’s Genomic Health Data platform, Europe’s first rare disease, advocacy-led genomic database. Maurice will also discuss how and why…

Open Orphan CCO Maurice Treacy discusses the early adopters of ORPH’s Genomic Health DataBANK platform on the Vox Markets Podcast November 26, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan (ORPH) – Early adopters signed for Genomic Health DataBANK November 25, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan (ORPH) Contract signed with Carna Bioscience November 18, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan (ORPH) to attend Jefferies 2019 London Healthcare Conference November 15, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan’s (ORPH) Maurice Treacy Hosts Value the Markets Webinar October 24, 2019 – Posted in: Open Orphan (ORPH)

Address

Contact

Social

LEGAL